ERYTECH to Present Preclinical Results Supporting Immunotherapy Potential of ERYMMUNE Platform at Two Upcoming Medical Meetings

ERYTECH today announced the presentation of encouraging preclinical data supporting the Company’s ERYMMUNE program at two upcoming immunotherapy medical meetings, World ADOPT Summit 2017 and 10th Symposium of Vaccinology. The World ADOPT Summit 2017 is being held March 7-9, 2017 at the Cavendish Conference Centre in London, U.K., and the 10th Symposium of Vaccinology is being held March 20-21, 2017 at the Université Lumière Lyon II in Lyon, France. In conjunction with the Symposium of Vaccinology, ERYTECH will also share the results with the members of the French Society of Immunology.

Menu